Accurate brain tumour segmentation is critical for diagnosis and treatment planning, yet challenging due to tumour complexity. Manual segmentation is time-consuming and variable, necessitating automated methods. Deep ...Accurate brain tumour segmentation is critical for diagnosis and treatment planning, yet challenging due to tumour complexity. Manual segmentation is time-consuming and variable, necessitating automated methods. Deep learning, particularly 3D U-Net architectures, has revolutionised medical image analysis by leveraging volumetric data to capture spatial context, enhancing segmentation accuracy. This paper reviews brain tumour segmentation methods, emphasising 3D U-Net advancements. We analyse contributions from the Brain Tumour Segmentation (BraTS) challenges (2014-2023), highlighting key improvements and persistent challenges, including tumour heterogeneity, limited annotated data, varied imaging protocols, computational constraints, and model generalisation. Unlike previous reviews, we synthesise these challenges, proposing targeted research directions: enhancing model robustness through domain adaptation and multi-institutional data sharing, developing lightweight architectures for clinical deployment, integrating multi-modal and clinical data, and incorporating explainability techniques to build clinician trust. By addressing these challenges, we aim to guide future research toward developing more robust, generalisable, and clinically applicable segmentation models, ultimately improving patient outcomes in neuro-oncology.展开更多
文摘Accurate brain tumour segmentation is critical for diagnosis and treatment planning, yet challenging due to tumour complexity. Manual segmentation is time-consuming and variable, necessitating automated methods. Deep learning, particularly 3D U-Net architectures, has revolutionised medical image analysis by leveraging volumetric data to capture spatial context, enhancing segmentation accuracy. This paper reviews brain tumour segmentation methods, emphasising 3D U-Net advancements. We analyse contributions from the Brain Tumour Segmentation (BraTS) challenges (2014-2023), highlighting key improvements and persistent challenges, including tumour heterogeneity, limited annotated data, varied imaging protocols, computational constraints, and model generalisation. Unlike previous reviews, we synthesise these challenges, proposing targeted research directions: enhancing model robustness through domain adaptation and multi-institutional data sharing, developing lightweight architectures for clinical deployment, integrating multi-modal and clinical data, and incorporating explainability techniques to build clinician trust. By addressing these challenges, we aim to guide future research toward developing more robust, generalisable, and clinically applicable segmentation models, ultimately improving patient outcomes in neuro-oncology.
